Monday - December 23, 2024

Antibody-Peptide Fusion Proteins for Treating Amyloid Disorders

2024-11-12

ALEXANDRIA, Virginia, Nov. 12 -- ATTRALUS, INC., Burlingame, California has been assigned a patent (No. US 12139529 B2, initially filed April 11, 2023) developed by five inventors Jonathan S. Wall, Knoxville, Tennessee; James S. Foster, Knoxville, Tennessee; Spencer Guthrie, San Francisco, California; Jaume Pons, San Francisco, California; and Michael L. Klein, San Francisco, California, for "Antibody-peptide fusion proteins for treating amyloid disorders." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Antibody-Peptide Fusion Proteins for Treating Amyloid Disorders

Information Request Form

Copyright Targeted News Service 2024